[1]
Dr Ekta Bhushan et al. 2025. EVALUATE DIAGNOSTIC ACCURACY OF NKX3.1 WITH AMACR & P63 IN PROSTATIC ADENOCARCINOMA. Journal of Population Therapeutics and Clinical Pharmacology. 32, 7 (Aug. 2025), 132–138. DOI:https://doi.org/10.53555/6svy7460.